Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2010 1
2011 2
2012 1
2013 2
2014 1
2015 2
2016 5
2017 1
2018 2
2019 5
2020 2
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Design of Internalizing PSMA-specific Glu-ureido-based Radiotherapeuticals.
Wüstemann T, Bauder-Wüst U, Schäfer M, Eder M, Benesova M, Leotta K, Kratochwil C, Haberkorn U, Kopka K, Mier W. Wüstemann T, et al. Among authors: leotta k. Theranostics. 2016 Apr 28;6(8):1085-95. doi: 10.7150/thno.13448. eCollection 2016. Theranostics. 2016. PMID: 27279903 Free PMC article.
Refined Chelator Spacer Moieties Ameliorate the Pharmacokinetics of PSMA-617.
Dos Santos JC, Schäfer M, Bauder-Wüst U, Beijer B, Eder M, Leotta K, Kleist C, Meyer JP, Dilling TR, Lewis JS, Kratochwil C, Kopka K, Haberkorn U, Mier W. Dos Santos JC, et al. Among authors: leotta k. Front Chem. 2022 Aug 9;10:898692. doi: 10.3389/fchem.2022.898692. eCollection 2022. Front Chem. 2022. PMID: 36017165 Free PMC article.
The pharmacokinetics of cell-penetrating peptides.
Sarko D, Beijer B, Garcia Boy R, Nothelfer EM, Leotta K, Eisenhut M, Altmann A, Haberkorn U, Mier W. Sarko D, et al. Among authors: leotta k. Mol Pharm. 2010 Dec 6;7(6):2224-31. doi: 10.1021/mp100223d. Epub 2010 Oct 7. Mol Pharm. 2010. PMID: 20845937
Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes.
Carlos Dos Santos J, Beijer B, Bauder-Wüst U, Schäfer M, Leotta K, Eder M, Benešová M, Kleist C, Giesel F, Kratochwil C, Kopka K, Haberkorn U, Mier W. Carlos Dos Santos J, et al. Among authors: leotta k. J Nucl Med. 2020 Jan;61(1):70-79. doi: 10.2967/jnumed.119.229054. Epub 2019 Sep 20. J Nucl Med. 2020. PMID: 31541034 Free article.
Bicyclic Peptides as a New Modality for Imaging and Targeting of Proteins Overexpressed by Tumors.
Eder M, Pavan S, Bauder-Wüst U, van Rietschoten K, Baranski AC, Harrison H, Campbell S, Stace CL, Walker EH, Chen L, Bennett G, Mudd G, Schierbaum U, Leotta K, Haberkorn U, Kopka K, Teufel DP. Eder M, et al. Among authors: leotta k. Cancer Res. 2019 Feb 15;79(4):841-852. doi: 10.1158/0008-5472.CAN-18-0238. Epub 2019 Jan 3. Cancer Res. 2019. PMID: 30606721
Development and dosimetry of 203Pb/212Pb-labelled PSMA ligands: bringing "the lead" into PSMA-targeted alpha therapy?
Dos Santos JC, Schäfer M, Bauder-Wüst U, Lehnert W, Leotta K, Morgenstern A, Kopka K, Haberkorn U, Mier W, Kratochwil C. Dos Santos JC, et al. Among authors: leotta k. Eur J Nucl Med Mol Imaging. 2019 May;46(5):1081-1091. doi: 10.1007/s00259-018-4220-z. Epub 2019 Jan 3. Eur J Nucl Med Mol Imaging. 2019. PMID: 30603987 Free PMC article.
22 results